Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
NCT00466180
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
62
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
BEHAVIORAL:
Nevirapine from twice-a-day to once-a-day
Sponsor
University Hospital, Caen